ESR1 and breast cancer: In ER+ BC, MAGI1 mutations or copy number alterations are rare (observed in less than 3% of all BC, and 2% within the ER+/HER2− BC dataset), indicating that in this particular case, DNA alterations are not the major cause of MAGI1 downregulation in this BC subtype.